Arch Biopartners Announces Appointment of Dr. Patrick Vink as Chairman of the Board
(TSX-V:ARCH),(OTC US:ACHFF),(Other OTC:ACHFF), TORONTO, Jan. 16, 2026 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today the appointment of Dr. Patrick Vink as Chairman of the Company's Board of Directors, effective January 15, 2026. Dr. Vink, M.D., M.B.A., has been an advisor to the pharmaceutical industry […]